These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 17570717)
1. A quantum mechanics/molecular mechanics study of the protein-ligand interaction for inhibitors of HIV-1 integrase. Alves CN; Martí S; Castillo R; Andrés J; Moliner V; Tuñón I; Silla E Chemistry; 2007; 13(27):7715-24. PubMed ID: 17570717 [TBL] [Abstract][Full Text] [Related]
2. Calculation of binding energy using BLYP/MM for the HIV-1 integrase complexed with the S-1360 and two analogues. Alves CN; Martí S; Castillo R; Andrés J; Moliner V; Tuñón I; Silla E Bioorg Med Chem; 2007 Jun; 15(11):3818-24. PubMed ID: 17420131 [TBL] [Abstract][Full Text] [Related]
3. A docking study of L-chicoric acid with HIV-1 integrase. Healy EF; Sanders J; King PJ; Robinson WE J Mol Graph Model; 2009 Jan; 27(5):584-9. PubMed ID: 19004651 [TBL] [Abstract][Full Text] [Related]
4. A quantum mechanic/molecular mechanic study of the wild-type and N155S mutant HIV-1 integrase complexed with diketo acid. Alves CN; Martí S; Castillo R; Andrés J; Moliner V; Tuñón I; Silla E Biophys J; 2008 Apr; 94(7):2443-51. PubMed ID: 17981909 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, molecular modeling, and anti-HIV-1 integrase activity of a series of photoactivatable diketo acid-containing inhibitors as affinity probes. Sechi M; Carta F; Sannia L; Dallocchio R; Dessì A; Al-Safi RI; Neamati N Antiviral Res; 2009 Mar; 81(3):267-76. PubMed ID: 19135482 [TBL] [Abstract][Full Text] [Related]
6. Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors. Chen X; Tsiang M; Yu F; Hung M; Jones GS; Zeynalzadegan A; Qi X; Jin H; Kim CU; Swaminathan S; Chen JM J Mol Biol; 2008 Jul; 380(3):504-19. PubMed ID: 18565342 [TBL] [Abstract][Full Text] [Related]
7. Rational design of novel diketoacid-containing ferrocene inhibitors of HIV-1 integrase. da Silva CH; Del Ponte G; Neto AF; Taft CA Bioorg Chem; 2005 Aug; 33(4):274-84. PubMed ID: 16023487 [TBL] [Abstract][Full Text] [Related]
8. Tn5 transposase as a useful platform to simulate HIV-1 integrase inhibitor binding mode. Barreca ML; Ortuso F; Iraci N; De Luca L; Alcaro S; Chimirri A Biochem Biophys Res Commun; 2007 Nov; 363(3):554-60. PubMed ID: 17889829 [TBL] [Abstract][Full Text] [Related]
9. From ligand to complexes. Part 2. Remarks on human immunodeficiency virus type 1 integrase inhibition by beta-diketo acid metal complexes. Bacchi A; Biemmi M; Carcelli M; Carta F; Compari C; Fisicaro E; Rogolino D; Sechi M; Sippel M; Sotriffer CA; Sanchez TW; Neamati N J Med Chem; 2008 Nov; 51(22):7253-64. PubMed ID: 18983138 [TBL] [Abstract][Full Text] [Related]
10. Metal-dependent inhibition of HIV-1 integrase by beta-diketo acids and resistance of the soluble double-mutant (F185K/C280S). Marchand C; Johnson AA; Karki RG; Pais GC; Zhang X; Cowansage K; Patel TA; Nicklaus MC; Burke TR; Pommier Y Mol Pharmacol; 2003 Sep; 64(3):600-9. PubMed ID: 12920196 [TBL] [Abstract][Full Text] [Related]
11. Insights into the interactions between HIV-1 integrase and human LEDGF/p75 by molecular dynamics simulation and free energy calculation. Zhao Y; Li W; Zeng J; Liu G; Tang Y Proteins; 2008 Aug; 72(2):635-45. PubMed ID: 18247352 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 IN strand transfer chelating inhibitors: a focus on metal binding. Bacchi A; Carcelli M; Compari C; Fisicaro E; Pala N; Rispoli G; Rogolino D; Sanchez TW; Sechi M; Neamati N Mol Pharm; 2011 Apr; 8(2):507-19. PubMed ID: 21323359 [TBL] [Abstract][Full Text] [Related]
14. HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching. Nicklaus MC; Neamati N; Hong H; Mazumder A; Sunder S; Chen J; Milne GW; Pommier Y J Med Chem; 1997 Mar; 40(6):920-9. PubMed ID: 9083480 [TBL] [Abstract][Full Text] [Related]
15. Conformationally restrained carbazolone-containing alpha,gamma-diketo acids as inhibitors of HIV integrase. Li X; Vince R Bioorg Med Chem; 2006 May; 14(9):2942-55. PubMed ID: 16386908 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr). Gleenberg IO; Herschhorn A; Hizi A J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682 [TBL] [Abstract][Full Text] [Related]
17. HIV integrase inhibitors as therapeutic agents in AIDS. Nair V; Chi G Rev Med Virol; 2007; 17(4):277-95. PubMed ID: 17503547 [TBL] [Abstract][Full Text] [Related]
18. Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods. Hu JP; He HQ; Tang DY; Sun GF; Zhang YQ; Fan J; Chang S J Biomol Struct Dyn; 2013; 31(7):734-47. PubMed ID: 22913375 [TBL] [Abstract][Full Text] [Related]
19. From ligand to complexes: inhibition of human immunodeficiency virus type 1 integrase by beta-diketo acid metal complexes. Sechi M; Bacchi A; Carcelli M; Compari C; Duce E; Fisicaro E; Rogolino D; Gates P; Derudas M; Al-Mawsawi LQ; Neamati N J Med Chem; 2006 Jul; 49(14):4248-60. PubMed ID: 16821784 [TBL] [Abstract][Full Text] [Related]
20. Insight into the inhibitory mechanism and binding mode between D77 and HIV-1 integrase by molecular modeling methods. Li P; Tan JJ; Liu M; Zhang XY; Chen WZ; Wang CX J Biomol Struct Dyn; 2011 Oct; 29(2):311-23. PubMed ID: 21875151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]